Integral Diagnostics Limited

CHIA:IDX Stock Report

Market Cap: AU$697.1m

Integral Diagnostics Management

Management criteria checks 1/4

Integral Diagnostics' CEO is Ian Kadish, appointed in May 2017, has a tenure of 7.67 years. total yearly compensation is A$1.24M, comprised of 66.3% salary and 33.7% bonuses, including company stock and options. directly owns 0.25% of the company’s shares, worth A$1.74M. The average tenure of the management team and the board of directors is 0.8 years and 1.4 years respectively.

Key information

Ian Kadish

Chief executive officer

AU$1.2m

Total compensation

CEO salary percentage66.3%
CEO tenure7.7yrs
CEO ownership0.3%
Management average tenureless than a year
Board average tenure1.4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Ian Kadish's remuneration changed compared to Integral Diagnostics's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024AU$1mAU$825k

-AU$61m

Mar 31 2024n/an/a

-AU$59m

Dec 31 2023n/an/a

-AU$58m

Sep 30 2023n/an/a

-AU$16m

Jun 30 2023AU$1mAU$794k

AU$25m

Mar 31 2023n/an/a

AU$23m

Dec 31 2022n/an/a

AU$21m

Sep 30 2022n/an/a

AU$18m

Jun 30 2022n/aAU$781k

AU$15m

Mar 31 2022n/an/a

AU$18m

Dec 31 2021n/an/a

AU$22m

Sep 30 2021n/an/a

AU$26m

Jun 30 2021AU$2mAU$736k

AU$31m

Mar 31 2021n/an/a

AU$32m

Dec 31 2020n/an/a

AU$32m

Sep 30 2020n/an/a

AU$28m

Jun 30 2020AU$1mAU$635k

AU$23m

Mar 31 2020n/an/a

AU$22m

Dec 31 2019n/an/a

AU$21m

Sep 30 2019n/an/a

AU$21m

Jun 30 2019AU$876kAU$549k

AU$21m

Mar 31 2019n/an/a

AU$19m

Dec 31 2018n/an/a

AU$17m

Sep 30 2018n/an/a

AU$16m

Jun 30 2018AU$711kAU$489k

AU$15m

Compensation vs Market: Ian's total compensation ($USD769.65K) is about average for companies of similar size in the Australian market ($USD868.30K).

Compensation vs Earnings: Ian's compensation has increased whilst the company is unprofitable.

CEO

Ian Kadish (61 yo)

7.7yrs

Tenure

AU$1,243,752

Compensation

Dr. Ian Kadish, MBBCh, MBA, serves as the Chief Executive Officer, Managing Director and a Director at Capitol Health Limited since December 11, 2024. He has been the Chief Executive Officer, Managing Dire...

Leadership Team

NamePositionTenureCompensationOwnership
Ian Kadish
CEO, MD & Director7.7yrsAU$1.24m0.25%
A$ 1.7m
Scott Paterson
Chief Financial Officerless than a yearno datano data
Julian Gully
Chief Information Officer5.3yrsno datano data
Justin Walter
Chief Integration Officerless than a yearno datano data
Tony Chen
Chief Medical Officerless than a yearno datano data
John Merity
Company Secretaryless than a yearno datano data

0.8yrs

Average Tenure

Experienced Management: IDX's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Ian Kadish
CEO, MD & Directorno dataAU$1.24m0.25%
A$ 1.7m
Raelene Murphy
Independent Non-Executive Director7.3yrsAU$140.53k0.013%
A$ 92.2k
Andrew Fay
Independent Non-Executive Director2.5yrsAU$137.50k0.036%
A$ 253.3k
Ingrid Player
Independent Non-Executive Director1.4yrsAU$111.22k0.015%
A$ 104.3k
James Hall
Independent Non-Executive Chairman1.3yrsAU$168.37k0.066%
A$ 457.6k
Laura McBain
Independent Non-Executive Directorless than a yearno data0.0063%
A$ 44.1k
Kai-Chung Shaw
Independent Non-Executive Directorless than a yearno datano data

1.4yrs

Average Tenure

59yo

Average Age

Experienced Board: IDX's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 18:11
End of Day Share Price 2025/01/10 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Integral Diagnostics Limited is covered by 24 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Russell WrightBarclay Pearce Capital Pty Limited
Thomas YeoBarrenjoey Markets Pty Limited
Saul HadassinBarrenjoey Markets Pty Limited